DaVita Stock Sees Rising Relative Strength
Novavax and Palantir rocket higher, while PayPal slumps and other stocks on the move
DaVita Is the S&P 500’s Top Gainer. Here’s Why the Dialysis Stock Is Surging.
DaVita Is the S&P 500's Top Gainer. Why the Dialysis Stock Is Surging.
Stock Market News
DaVita 1Q Rev $2.87B >DVA
Aerospace Executives Go to Trial Over Alleged No-Poach Deals
Junk Bonds Rally on Hopes Inflation Has Peaked
Unprofitable public companies gambled more than $200 million in California, and lost big
Dialysis company DaVita stock suffered worst day in 22 years after big profit miss, disappointing outlook
DaVita Stock Plummets Most Since 2000 on Outlook Cut
DaVita stock falls as higher wages, missed treatments push earnings below Street expectations
First Criminal Wage-Fixing Trials End in Loss for DOJ
Not Sure How Much You Should Be Paid? Colorado Could Offer Some Clues
Active Funds Are Doing Better. This Is What's Helping Them.
DaVita and its former CEO indicted, Justice Department charges illegal 'no poaching' deals with rivals
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.